BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38221567)

  • 1. CEACAM5 and TROP2 define metaplastic and dysplastic transitions in human antral gastric precancerous lesions and tumors.
    Jang B; Lee SH; Dovirak I; Kim H; Srivastava S; Teh M; Yeoh KG; So JB; Tsao SKK; Khor CJ; Ang TL; Goldenring JR
    Gastric Cancer; 2024 Mar; 27(2):263-274. PubMed ID: 38221567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trop2 is upregulated in the transition to dysplasia in the metaplastic gastric mucosa.
    Riera KM; Jang B; Min J; Roland JT; Yang Q; Fesmire WT; Camilleri-Broet S; Ferri L; Kim WH; Choi E; Goldenring JR
    J Pathol; 2020 Jul; 251(3):336-347. PubMed ID: 32432338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CEACAM5 has different expression patterns in gastric non-neoplastic and neoplastic lesions and cytoplasmic staining is a marker for evaluation of tumor progression in gastric adenocarcinoma.
    Liu JN; Wang HB; Zhou CC; Hu SY
    Pathol Res Pract; 2014 Oct; 210(10):686-93. PubMed ID: 25042385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of CEACAM5 as a Biomarker for Prewarning and Prognosis in Gastric Cancer.
    Zhou J; Fan X; Chen N; Zhou F; Dong J; Nie Y; Fan D
    J Histochem Cytochem; 2015 Dec; 63(12):922-30. PubMed ID: 26374829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation reprogramming in gastric intestinal metaplasia and dysplasia: role of SOX2 and CDX2.
    Camilo V; Garrido M; Valente P; Ricardo S; Amaral AL; Barros R; Chaves P; Carneiro F; David L; Almeida R
    Histopathology; 2015 Feb; 66(3):343-50. PubMed ID: 25196071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal metaplasia of the stomach and esophagus: an immunohistochemical study of 60 cases including comparison with normal and inflamed intestinal mucosa.
    Chlumská A; Mukenšnabl P; Mareček P; Zámečník M
    Cesk Patol; 2014 Jul; 50(3):141-8. PubMed ID: 25186595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cathepsin E and subtypes of intestinal metaplasia in carcinogenesis of the human stomach.
    Lin CK; Lai KH; Lo GH; Cheng JS; Hsu PI; Mok KT; Tseng HH
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jun; 64(6):331-6. PubMed ID: 11534800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of Aquaporin 5 Defines Spasmolytic Polypeptide-Expressing Metaplasia and Progression to Incomplete Intestinal Metaplasia.
    Lee SH; Jang B; Min J; Contreras-Panta EW; Presentation KS; Delgado AG; Piazuelo MB; Choi E; Goldenring JR
    Cell Mol Gastroenterol Hepatol; 2022; 13(1):199-217. PubMed ID: 34455107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of polymorphisms in myeloperoxidase and catalase genes with precancerous changes in the gastric mucosa of patients at inner-city hospitals in New York.
    Steenport M; Eom H; Uezu M; Schneller J; Gupta R; Mustafa Y; Villanueva R; Straus EW; Raffaniello RD
    Oncol Rep; 2007 Jul; 18(1):235-40. PubMed ID: 17549373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spasmolytic polypeptide-expressing metaplasia (SPEM) associated with gastric cancer in Iceland.
    Halldórsdóttir AM; Sigurdardóttrir M; Jónasson JG; Oddsdóttir M; Magnússon J; Lee JR; Goldenring JR
    Dig Dis Sci; 2003 Mar; 48(3):431-41. PubMed ID: 12757153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incomplete Intestinal Metaplasia Is Rare in Autoimmune Gastritis.
    Genta RM; Turner KO; Robiou C; Singhal A; Rugge M
    Dig Dis; 2023; 41(3):369-376. PubMed ID: 36739859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of intestinal metaplasia in gastric biopsy of patients with dyspepsia in Guilan Province, North Iran.
    Mansour-Ghanaei F; Joukar F; Soati F; Mansour-Ghanaei A; Atrkar-Roushan Z
    Asian Pac J Cancer Prev; 2013; 14(6):3549-54. PubMed ID: 23886143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of GCRG213p, LINE-1 endonuclease variant, significantly different in gastric complete and incomplete intestinal metaplasia.
    Duan X; Lian H; Li J; Wu B; Wang W; Wu T; Wang C; Dou Y; Zhou Z; Wang B; Xue L; Wang G
    Diagn Pathol; 2019 Jun; 14(1):61. PubMed ID: 31221180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD10 and Das1: a biomarker study using immunohistochemistry to subtype gastric intestinal metaplasia.
    Koulis A; Di Costanzo N; Mitchell C; Lade S; Goode D; Busuttil RA; Boussioutas A
    BMC Gastroenterol; 2022 Apr; 22(1):197. PubMed ID: 35448971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric intestinal metaplasia: Long-term follow-up results.
    Rakici H; Uyanik E; Rakici IM; Polat HB; Akdogan RA; Aydin G; Ayvaz MA; Bedir R
    Niger J Clin Pract; 2022 Mar; 25(3):315-324. PubMed ID: 35295055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphiregulin-deficient mice develop spasmolytic polypeptide expressing metaplasia and intestinal metaplasia.
    Nam KT; Lee HJ; Mok H; Romero-Gallo J; Crowe JE; Peek RM; Goldenring JR
    Gastroenterology; 2009 Apr; 136(4):1288-96. PubMed ID: 19230855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression study and pathway analysis of histological subtypes of intestinal metaplasia that progress to gastric cancer.
    Companioni O; Sanz-Anquela JM; Pardo ML; Puigdecanet E; Nonell L; García N; Parra Blanco V; López C; Andreu V; Cuatrecasas M; Garmendia M; Gisbert JP; Gonzalez CA; Sala N
    PLoS One; 2017; 12(4):e0176043. PubMed ID: 28441455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenomatous and foveolar gastric dysplasia: distinct patterns of mucin expression and background intestinal metaplasia.
    Park DY; Srivastava A; Kim GH; Mino-Kenudson M; Deshpande V; Zukerberg LR; Song GA; Lauwers GY
    Am J Surg Pathol; 2008 Apr; 32(4):524-33. PubMed ID: 18300795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Colombian Chemoprevention Trial: 20-Year Follow-Up of a Cohort of Patients With Gastric Precancerous Lesions.
    Piazuelo MB; Bravo LE; Mera RM; Camargo MC; Bravo JC; Delgado AG; Washington MK; Rosero A; Garcia LS; Realpe JL; Cifuentes SP; Morgan DR; Peek RM; Correa P; Wilson KT
    Gastroenterology; 2021 Mar; 160(4):1106-1117.e3. PubMed ID: 33220252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and significance of homeodomain protein Cdx2 in gastric carcinoma and precancerous lesions.
    Qin R; Wang NN; Chu J; Wang X
    World J Gastroenterol; 2012 Jul; 18(25):3296-302. PubMed ID: 22783055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.